[ Fri, Feb 04th 2022 ]: WOPRAI
[ Fri, Feb 04th 2022 ]: WOPRAI
[ Fri, Feb 04th 2022 ]: WOPRAI
[ Fri, Feb 04th 2022 ]: WOPRAI
[ Fri, Feb 04th 2022 ]: WOPRAI
[ Fri, Feb 04th 2022 ]: WOPRAI
[ Fri, Feb 04th 2022 ]: WOPRAI
[ Fri, Feb 04th 2022 ]: WOPRAI
[ Fri, Feb 04th 2022 ]: WOPRAI
[ Fri, Feb 04th 2022 ]: WOPRAI
[ Fri, Feb 04th 2022 ]: WOPRAI
[ Fri, Feb 04th 2022 ]: WOPRAI
[ Fri, Feb 04th 2022 ]: WOPRAI
[ Fri, Feb 04th 2022 ]: WOPRAI
[ Fri, Feb 04th 2022 ]: WOPRAI
[ Fri, Feb 04th 2022 ]: WOPRAI
[ Fri, Feb 04th 2022 ]: WOPRAI
[ Fri, Feb 04th 2022 ]: WOPRAI
[ Fri, Feb 04th 2022 ]: WOPRAI
[ Fri, Feb 04th 2022 ]: WOPRAI
[ Fri, Feb 04th 2022 ]: WOPRAI
[ Fri, Feb 04th 2022 ]: WOPRAI
[ Fri, Feb 04th 2022 ]: WOPRAI
[ Fri, Feb 04th 2022 ]: WOPRAI
[ Fri, Feb 04th 2022 ]: WOPRAI
[ Fri, Feb 04th 2022 ]: WOPRAI
[ Fri, Feb 04th 2022 ]: WOPRAI
[ Fri, Feb 04th 2022 ]: WOPRAI
[ Fri, Feb 04th 2022 ]: WOPRAI
[ Fri, Feb 04th 2022 ]: WOPRAI
[ Fri, Feb 04th 2022 ]: WOPRAI
[ Fri, Feb 04th 2022 ]: WOPRAI
[ Fri, Feb 04th 2022 ]: WOPRAI
[ Fri, Feb 04th 2022 ]: WOPRAI
[ Fri, Feb 04th 2022 ]: WOPRAI
[ Fri, Feb 04th 2022 ]: WOPRAI
[ Fri, Feb 04th 2022 ]: WOPRAI
[ Fri, Feb 04th 2022 ]: WOPRAI
[ Fri, Feb 04th 2022 ]: WOPRAI
[ Fri, Feb 04th 2022 ]: WOPRAI
[ Fri, Feb 04th 2022 ]: WOPRAI
[ Fri, Feb 04th 2022 ]: WOPRAI
[ Fri, Feb 04th 2022 ]: WOPRAI
[ Fri, Feb 04th 2022 ]: WOPRAI
[ Fri, Feb 04th 2022 ]: WOPRAI
[ Fri, Feb 04th 2022 ]: WOPRAI
[ Fri, Feb 04th 2022 ]: WOPRAI
[ Fri, Feb 04th 2022 ]: WOPRAI
Jailendra Singh Maintained (CAH) at Hold with Decreased Target to $58 on, Feb 4th, 2022
- 🞛 This publication is a summary or evaluation of another publication
Jailendra Singh of Credit Suisse, Maintained "Cardinal Health, Inc." (CAH) at Hold with Decreased Target from $60 to $58 on, Feb 4th, 2022.
Jailendra has made no other calls on CAH in the last 4 months.
There are 2 other peers that have a rating on CAH. Out of the 2 peers that are also analyzing CAH, 1 agrees with Jailendra's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Ricky Goldwasser of "Morgan Stanley" Maintained at Hold with Decreased Target to $54 on, Friday, December 17th, 2021
This is the rating of the analyst that currently disagrees with Jailendra
- Steve Valiquette of "Barclays" Maintained at Buy with Decreased Target to $63 on, Tuesday, January 11th, 2022